A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Clinical trial NCT05499130 · COMPLETED
Trial details
- NCT number
- NCT05499130
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2024-11-12
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.